1
Home
Companies

BARD1 Life Sciences

BARD1 Life Sciences
Leadership team

Geoffrey J. Cumming (Independent Non-Executive Chairman)

Samuel Janes (Member of Advisory Board)

Philip John Powell (Independent Non-Executive Director)

Products/ Services
Biotechnology, Health Diagnostics, Life Science
Number of Employees
0 - 50
Headquarters
Nedlands, Western Australia, Australia
Established
1983
Traded as
ASX:BD1
Social Media
URL
www.bard1.com/
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
BARD1 Life Sciences (formerly, BARD1 Diagnostics) is an Australian biotech company whose mission is to develop and deliver innovative diagnostics to improve the health of patients. The company specializes in the development of cancer diagnostics based on its patented BARD1 gene, which has been linked to a number of cancer types.
History

BARD1 Life Sciences was founded in 2008 by Professor Graeme Suthers and Philip Watson who had done significant research on the BARD1 gene together. BARD1’s research and development team have been pioneers in the discovery and development of the BARD1 gene, which is the focus of the company’s innovative cancer diagnostics. In recent years, BARD1 has established a growing customer base in both the US and Australia and has developed partnerships with key global firms.

Mission
BARD1 Life Sciences is dedicated to providing innovative diagnostics to improve the health of our patients. We are committed to developing and validating diagnostics that are accurate, reliable and clinically relevant.
Vision
BARD1 Life Sciences vision is to be a leader in the innovation of cancer diagnostics that support early and accurate diagnosis of cancer, thereby improving patient outcomes.
Key Team

Robert Maxwell Johnston (Independent Non-Executive Director)

Geoffrey McCaughan (Member of Advisory Board)

Raoul S. Concepcion (Member of Advisory Board)

Recognition and Awards
BARD1 has been recognized in the area of cancer diagnostics, including a Best Biotech Startup in Australia by the Australian Medical Device Industry Awards in 2018, the Sydney Business Awards for Excellence in Biotechnology & Life Sciences in 2016, and the NSW Medical Technology Association Innovation Award in 2015.
References

https://in.investing.com/equities/eurogold-ltd

https://www.crunchbase.com/organization/bard1-life-sciences-ltd

www.bard1.com/

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

BARD1 Life Sciences
Leadership team

Geoffrey J. Cumming (Independent Non-Executive Chairman)

Samuel Janes (Member of Advisory Board)

Philip John Powell (Independent Non-Executive Director)

Products/ Services
Biotechnology, Health Diagnostics, Life Science
Number of Employees
0 - 50
Headquarters
Nedlands, Western Australia, Australia
Established
1983
Traded as
ASX:BD1
Social Media
URL
www.bard1.com/